Expanding the Role of Complement Therapies: The Case for Lupus Nephritis

por Li, Nicholas L., Birmingham, Daniel J., Rovin, Brad H.
Publicado 2021

Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers

por Budu-Grajdeanu, Paula, Schugart, Richard C, Friedman, Avner, Birmingham, Daniel J, Rovin, Brad H
Publicado 2010

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare

por Toy, Chris R., Song, Huijuan, Nagaraja, Haikady N., Scott, Julia, Greco, Jessica, Zhang, Xiaolan, Yu, Chack-Yung, Tumlin, James A., Rovin, Brad H., Hebert, Lee A., Birmingham, Daniel J.
Publicado 2021

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

por Diaz‐Gallo, Lina‐Marcela, Oke, Vilija, Lundström, Emeli, Elvin, Kerstin, Ling Wu, Yee, Eketjäll, Susanna, Zickert, Agneta, Gustafsson, Johanna T., Jönsen, Andreas, Leonard, Dag, Birmingham, Daniel J., Nordmark, Gunnel, Bengtsson, Anders A., Rönnblom, Lars, Gunnarsson, Iva, Yu, Chack‐Yung, Padyukov, Leonid, Svenungsson, Elisabet
Publicado 2021

Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases

por Zhou, Danlei, Rudnicki, Michael, Chua, Gilbert T., Lawrance, Simon K., Zhou, Bi, Drew, Joanne L., Barbar-Smiley, Fatima, Armstrong, Taylor K., Hilt, Miranda E., Birmingham, Daniel J., Passler, Werner, Auletta, Jeffrey J., Bowden, Sasigarn A., Hoffman, Robert P., Wu, Yee Ling, Jarjour, Wael N., Mok, Chi Chiu, Ardoin, Stacy P., Lau, Yu Lung, Yu, Chack Yung
Publicado 2021